Current Consultations
Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.
The following lists both consultations and invitations to make submissions which are relevant to health and medical research and/or health and innovation policy in Australia. Research Australia updates this regularly but we may not participate in every one listed.
If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia via email greg.mullins@researchaustralia.org or phone (03) 9662 9420.
Please click the heading in the left hand column to access consultation information from the relevant website.
Consultation |
Details |
TGA Advertising Code
Due 18 June |
The Therapeutic Goods Administration (TGA) is seeking feedback on options to improve the Therapeutic Goods Advertising Code (No.2) 2018 (the Code). The Code is the compliance standard that prescribes the minimum requirements for the lawful advertising of therapeutic goods to the general public in Australia. |
Select Committee on COVID-19
|
On 8 April 2020, the Senate resolved to establish a Select Committee on COVID-19 to inquire into the Australian Government’s response to the COVID-19 pandemic.
The terms of reference are very broad:
Research Australia has made a submission to the Inquiry, which is available here. The Committee is to present its final report on or before 30 June 2022. |